Related Experiment Video
Updated: Jun 12, 2025

06:44
Confocal Imaging of Double-Stranded RNA and Pattern Recognition Receptors in Negative-Sense RNA Virus Infection
Published on: January 26, 2019
7.8K
RNA Design Using incaRNAfbinv Demonstrated with the Identification of Functional RNA Motifs in Hepatitis Delta Virus
Rami Zakh1,2, Alexander Churkin3, Danny Barash4
1Department of Computer Science, Ben-Gurion University, Beer-Sheva, Israel. zakhr@post.bgu.ac.il.
Methods in Molecular Biology (Clifton, N.J.)
|September 23, 2024
Summary
incaRNAfbinv 2.0 is a web-server for computational RNA design, using fragment-based inverse RNA folding. It aids in designing synthetic RNAs and locating functional RNA motifs in genomic data.
Area of Science:
- Computational biology
- Molecular biology
- Bioinformatics
Background:
- Computational RNA design evolved from early inverse folding solvers like RNAinverse.
- Modern techniques offer enhanced efficiency and control over RNA sequence design.
- incaRNAfbinv builds upon RNAinverse, incorporating fragment-based approaches for RNA secondary structure design.
Purpose of the Study:
- To introduce incaRNAfbinv 2.0, a free web-server for advanced computational RNA design.
- To demonstrate the utility of fragment-based inverse RNA folding for both synthetic RNA design and functional motif discovery.
- To showcase the application of incaRNAfbinv 2.0 in identifying RNA motifs across different genomic contexts.
Main Methods:
- Decomposition of RNA secondary structures into functional motifs.
- Utilizing a fragment-based inverse RNA folding approach.
- Implementing flexible constraint insertion and motif selection within the incaRNAfbinv 2.0 web-server.
Main Results:
- The incaRNAfbinv 2.0 web-server provides precise control over RNA secondary structure motif design.
- Designed RNA sequences are ranked based on their similarity to known RNA structures.
- The tool successfully identified a functional RNA motif in hepatitis delta virus (HDV) across multiple genotypes.
Conclusions:
- Computational RNA design using inverse folding is effective for creating synthetic RNAs.
- This approach is also a valuable strategy for discovering functional RNA motifs within genomic data.
- incaRNAfbinv 2.0 enhances RNA design capabilities by integrating fragment-based methods and flexible constraints.
Related Concept Videos
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Ribozymes
11.2K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
11.2K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K

